Revolutionizing Blood Pressure Monitoring: Biozen's Cuffless Technology at AHA 2025
Biozen Showcases Calibration-Free, Cuffless Blood Pressure Technology at AHA 2025
Biozen, LLC, a pioneering company in the digital health sector, is set to unveil its groundbreaking cuffless blood pressure technology at the prestigious American Heart Association (AHA) Hypertension Scientific Sessions. This event will take place on September 5, 2025, in Baltimore, Maryland, where Biozen will present its innovative technology that allows for absolute blood pressure measurement directly from the fingertip.
The Biozen BP1000 Device
The centerpiece of Biozen's presentation will be the Biozen BP1000, designed to deliver accurate blood pressure readings without the cumbersome cuff traditionally associated with blood pressure monitoring. The technology leverages the oscillometric method, which is recognized as a reliable standard in blood pressure measurement. By removing the bulk and discomfort of conventional methods, Biozen's device promises a more user-friendly experience for patients and healthcare providers alike.
At the heart of the BP1000 is the Biozen BP Sensor, a sophisticated System in Package (SiP) that integrates optical and pressure sensors. This sensor technology will soon be adaptable for smartphones and wearables, enhancing the convenience of blood pressure monitoring by allowing users to check their readings anytime and anywhere.
Addressing Hypertension Globally
Hypertension is a major health issue worldwide, affecting approximately 1.3 billion adults. Alarmingly, many remain unaware of their condition. Biozen's CEO, Dikran Tourian, emphasizes that their mission transcends mere device creation; they aspire to foster a comprehensive digital health ecosystem. "We aim to empower both patients and health providers with easily accessible blood pressure monitoring technology. Our innovations are geared towards early detection and management of hypertension worldwide,” he stated.
Biozen is committed to merging regulatory standards with innovative scalability. It seeks to ensure its cuffless, calibration-free blood pressure monitoring solutions are widely available, benefiting not just those diagnosed with hypertension, but anyone at risk.
The Future of Blood Pressure Monitoring
As Biozen prepares for its presentation at the AHA sessions, the company is dedicated to advancing clinical validation of its technology. Biozen's approach of pairing their BP Sensor with proprietary algorithms is indicative of its commitment to reliability and accuracy in health technology.
Currently, the Biozen BP Sensor and the BP1000 are in investigational stages and have not yet received FDA clearance for commercial use. However, the ambitious plans for integrating this technology into everyday devices mark a significant shift in how people will monitor their blood pressure in the future.
Based in Oklahoma City, Oklahoma, with research and development arms in Atlanta, Georgia, and software operations in Austin, Texas, Biozen is protected by over 65 patents across the U.S. and internationally. This intellectual property underscores the innovative nature of their technology, as they pave the way toward a more efficient and user-friendly health monitoring future.
For further information about Biozen and its cutting-edge technology, visit their official website at www.biozen.com. For media inquiries, reach out to Ashley Wilson at +1 405-413-5201.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.